Cost-effectiveness analysis of gender-stratified Plasmodium vivax treatment strategies using available g6pd diagnostics to accelerate access to radical cure

Tafenoquine has been licensed for the single-dose radical cure of Plasmodium vivax in adults; however, it is only recommended in patients with > 70% of normal glucose-6-phosphate dehydrogenase (G6PD) activity. Because this may hinder widespread use, we investigated gender-based treatment strategi...

Cijeli opis

Bibliografski detalji
Glavni autori: Devine, A, Howes, RE, Price, DJ, Moore, KA, Ley, B, Simpson, JA, Dittrich, S, Price, RN
Format: Journal article
Jezik:English
Izdano: American Society of Tropical Medicine and Hygiene 2020

Slični predmeti